Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Clinical trial NCT05929495 · RECRUITING

Trial details

NCT number: NCT05929495
Sponsor: University of Milano Bicocca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma, IDH-wildtype Metformin Malignancies

Start date: 2024-02-12
Primary completion: 2026-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.